Chempartner Pharmatech Co (SZSE:300149) Total Liabilities : ¥767 Mil (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Chempartner Pharmatech Co Total Liabilities?

Chempartner Pharmatech Co's Total Liabilities for the quarter that ended in Sep. 2024 was ¥767 Mil.

Chempartner Pharmatech Co's quarterly Total Liabilities declined from Mar. 2024 (¥909.15 Mil) to Jun. 2024 (¥858.09 Mil) and declined from Jun. 2024 (¥858.09 Mil) to Sep. 2024 (¥766.98 Mil).

Chempartner Pharmatech Co's annual Total Liabilities declined from Dec. 2021 (¥2,228.52 Mil) to Dec. 2022 (¥1,437.94 Mil) and declined from Dec. 2022 (¥1,437.94 Mil) to Dec. 2023 (¥973.44 Mil).

Chempartner Pharmatech Co Total Liabilities Historical Data

The historical data trend for Chempartner Pharmatech Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chempartner Pharmatech Co Total Liabilities Chart

Chempartner Pharmatech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1,464.37

1,669.19

2,228.52

1,437.94

973.44

Chempartner Pharmatech Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															1,056.51	973.44	909.15	858.09	766.98

Chempartner Pharmatech Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Chempartner Pharmatech Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	426.775	+	(501.405	+	45.257
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	973

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	2434.323	-	1460.886
	=	973

Chempartner Pharmatech Co's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	347.227	+	(387.074	+	32.678
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	767

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	2156.649	-	1389.669
	=	767

Chempartner Pharmatech Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Chempartner Pharmatech Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Chempartner Pharmatech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chempartner Pharmatech Co Ltd (SZSE:300149) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 268 Dongfeng Middle Road, 28th Floor, Exchange Square, Yuexiu District, Guangzhou City, Guangdong, CHN, 529081

Website

https://www.cppt.com.cn

Chempartner Pharmatech Co Ltd is engaged in the research, development, production, and operation of prebiotics, micro-ecological medical, and biopharmaceuticals.

Executives

Qi Jia Hui	Supervisors
Yang Xin Qiu	Executives
Ceng Xian Jing	Director
Xie Yong Kui	Director
Zhou Xin Ping	Director
Wang Cong Wei	Director

Chempartner Pharmatech Co Headlines

No Headlines